Pathophysiology of nausea and vomiting in palliative medicine

被引:10
作者
Smith, Howard S. [1 ]
Smith, Eric J. [1 ]
Smith, Alyssa R. [1 ]
机构
[1] Albany Med Coll, Dept Anesthesiol, Albany, NY 12208 USA
关键词
Nausea; vomiting; NK-1; antagonists; 5HT-3;
D O I
10.3978/j.issn.2224-5820.2012.07.04
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Nausea/vomiting remains a significant problem in medicine, especially in patients with chronic illnesses. The incidence and patient distress level from nausea and vomiting are underestimated by health care providers. A thorough patient evaluation followed by rational polypharmacy and a multimodal treatment approach may minimize the occurrence and intensity of nausea/vomiting. Utilizing new techniques (e.g., PET imaging of the CNS with novel radiotracers, functional Magnetic Resonance Imaging), clinicians could have a greater chance to elucidate which receptors may be contributing to an individual's experience of nausea and vomiting and the relative importance of each. Future research into assessing precise mechanisms of nausea and vomiting in particular patients may enable clinicians to design the most appropriate combinations of antiemetics in efforts to achieve the most effective therapy with the least side effects. Individually-tailored antiemetic "cocktails," based on patient specific pathophysiology, may lead to optimal treatment outcomes.
引用
收藏
页码:87 / 93
页数:7
相关论文
共 33 条
[1]   Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction [J].
Andrews, PLR ;
Sanger, GJ .
CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (06) :650-656
[2]   FUNCTIONAL LOCALIZATION OF CENTRAL COORDINATING MECHANISM FOR EMESIS IN CAT [J].
BORISON, HL ;
WANG, SC .
JOURNAL OF NEUROPHYSIOLOGY, 1949, 12 (05) :305-313
[3]  
Cleeland CS, 2000, CANCER-AM CANCER SOC, V89, P1634, DOI 10.1002/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO
[4]  
2-V
[5]   Oxyntomodulin suppresses appetite and reduces food intake in humans [J].
Cohen, MA ;
Ellis, SM ;
Le Roux, CW ;
Batterham, RL ;
Park, A ;
Patterson, M ;
Frost, GS ;
Ghatei, MA ;
Bloom, SR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (10) :4696-4701
[6]  
del Giglio A, 2000, CANCER, V89, P2301, DOI 10.1002/1097-0142(20001201)89:11<2301::AID-CNCR19>3.0.CO
[7]  
2-6
[8]  
Donnerer J., 2003, P22, DOI 10.1159/000071409
[9]  
Donnerer Josef, 2003, P1, DOI 10.1159/000071406
[10]   SELECTIVITY OF 5-HT3 RECEPTOR ANTAGONISTS AND ANTIEMETIC MECHANISMS OF ACTION [J].
FREEMAN, AJ ;
CUNNINGHAM, KT ;
TYERS, MB .
ANTI-CANCER DRUGS, 1992, 3 (02) :79-85